Molbio Diagnostics shares surged 20% on September 10, 2026, reaching an all-time high of ₹1,509.70. The company reported a profit of ₹52.74 crore for Q1 FY27 and a sharp increase in Truenat test-kit volumes, reinforcing its strong market position and optimistic future outlook.